Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Li, Jian ^a   Li, Dan ^a   Gong, Feirong ^b   Jiang, Shaoyan ^a   Yu, Hua ^a   An, Yi ^a  

^a QINGDAO UNIVERSITY   (China)

^b East China University of Science and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD 133 ANTIBODY; CELL ANTIBODY; IMMOBILIZED ANTIBODY; UNCLASSIFIED DRUG; CD133 ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; METAL; PEPTIDE; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTICLE; BARE METAL STENT; BLOOD FLOW; CD 133 ANTIBODY STENT; CELL CULTURE; CIRCULATION; CONJUGATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY INJURY; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EPITHELIZATION; FLUORESCENCE; FLUORESCENCE MICROSCOPY; FOLLOW UP; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MATERIAL COATING; NONHUMAN; POLYMERIZATION; ANIMAL; CELL SEPARATION; CHEMISTRY; CYTOLOGY; ENDOTHELIUM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PIG; SCANNING ELECTRON MICROSCOPY; STEM CELL; STENT; SURFACE PROPERTY;

ANIMALS; ANTIBODIES, IMMOBILIZED; ANTIGENS, CD; ANTIGENS, CD34; CELL SEPARATION; CELLS, CULTURED; ENDOTHELIUM; FLOW CYTOMETRY; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; METALS; MICROSCOPY, ELECTRON, SCANNING; PEPTIDES; POLYMERS; STEM CELLS; STENTS; SURFACE PROPERTIES; SWINE;

EID: 84897488918     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/902782     Document Type: Article

References (24)

1. Sousa J. E., Costa M. A., Sousa A. G. M. R., Abizaid A. C., Seixas A. C., Abizaid A. S., Feres F., Mattos L. A., Falotico R., Jaeger J., Popma J. J., Serruys P. W., Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003 107 3 381 383 2-s2.0-0037469230 10.1161/01.CIR.0000051720. 59095.6D (Pubitemid 36158039)
2. Stone G. W., Ellis S. G., Cox D. A., Hermiller J., O'Shaughnessy C., Mann J. T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J. J., Russell M. E., A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. The New England Journal of Medicine 2004 350 3 221 231 2-s2.0-9144249927 10.1056/NEJMoa032441 (Pubitemid 38067635)
3. Serruvs P. W., Morice M.-C., Kappetein A. P., Colombo A., Holmes D. R., Mack M. J., Ståhle E., Feldman T. E., van den Brand M., Bass E. J., van Dyck N., Leadley K., Dawkins K. D., Mohr F. W., Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Journal of Medicine 2009 360 10 961 972 2-s2.0-61849104535 10.1056/NEJMoa0804626
4. Shen L., Gong F. R., Tian W. J., Anti-inammatory effect of arenic trioide eluting stent in a porcine coronary model. BioMed Research International 2013 2013 9 937936 10.1155/2013/937936
5. Kotani J.-I., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., Mintz G. S., Nagata S., Incomplete neointimal coverage of sirolimus-eluting stents. Angioscopic findings. Journal of the American College of Cardiology 2006 47 10 2108 2111 2-s2.0-33646252464 10.1016/j.jacc.2005.11.092
6. Wilson G. J., Nakazawa G., Schwartz R. S., Huibregtse B., Poff B., Herbst T. J., Baim D. S., Virmani R., Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009 120 2 141 149 2-s2.0-67651119696 10.1161/ CIRCULATIONAHA.107.730010
7. Hofma S. H., van der Giessen W. J., van Dalen B. M., Lemos P. A., McFadden E. P., Sianos G., Ligthart J. M. R., van Essen D., de Feyter P. J., Serruys P. W., Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. European Heart Journal 2006 27 2 166 170 2-s2.0-30344439818 10.1093/eurheartj/ehi571 (Pubitemid 43069032)
8. Finn A. V., Joner M., Nakazawa G., Kolodgie F., Newell J., John M. C., Gold H. K., Virmani R., Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007 115 18 2435 2441 2-s2.0-34248219973 10.1161/CIRCULATIONAHA.107.693739 (Pubitemid 46717966)
9. Gong F., Cheng X., Wang S., Zhao Y., Gao Y., Cai H., Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomaterialia 2010 6 2 534 546 2-s2.0-72049107725 10.1016/j.actbio.2009.07.013
10. Robinson K. A., Roubin G., King S., Siegel R., Rodgers G., Apkarian R. P., Correlated microscopic observations of arterial responses to intravascular stenting. Scanning Microscopy 1989 3 2 665 679 2-s2.0-0024811658 (Pubitemid 20022048)
11. Banerjee S., Brilakis E., Zhang S., Roesle M., Lindsey J., Philips B., Blewett C. G., Terada L. S., Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006 189 1 70 75 2-s2.0-33748976490 10.1016/j.atherosclerosis.2006.04.026 (Pubitemid 44441298)
12. Shirota T., Yasui H., Shimokawa H., Matsuda T., Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003 24 13 2295 2302 2-s2.0-12444320975 10.1016/S0142-9612(03)00042-5 (Pubitemid 36434048)
13. Co M., Tay E., Lee C. H., Poh K. K., Low A., Lim J., Lim I. H., Lim Y. T., Tan H. C., Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. The American Heart Journal 2008 155 1 128 132 2-s2.0-36849016019 10.1016/j.ahj.2007.08.031 (Pubitemid 350234778)
14. Aoki J., Serruys P. W., van Beusekom H., Ong A. T. L., McFadden E. P., Sianos G., van der Giessen W. J., Regar E., de Feyter P. J., Davis H. R., Rowland S., Kutryk M. J. B., Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry. Journal of the American College of Cardiology 2005 45 10 1574 1579 2-s2.0-21044445480 10.1016/j.jacc.2005.01.048 (Pubitemid 40704488)
15. Larsen K., Cheng C., Tempel D., Parker S., Yazdani S., den Dekker W. K., Houtgraaf J. H., de Jong R., Swager-Ten Hoor S., Ligtenberg E., Hanson S. R., Rowland S., Kolodgie F., Serruys P. W., Virmani R., Duckers H. J., Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. European Heart Journal 2012 33 1 120 128 2-s2.0-84855498912 10.1093/eurheartj/ ehr196
16. Beijk M. A. M., Klomp M., Verouden N. J. W., van Geloven N., Koch K. T., Henriques J. P. S., Baan J., Vis M. M., Scheunhage E., Piek J. J., Tijssen J. G. P., de Winter R. J., Genous endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. European Heart Journal 2010 31 9 1055 1064 2-s2.0-77952053261 10.1093/eurheartj/ehp476
17. Beijk M. A. M., Klomp M., Van Geloven N., Koch K. T., Henriques J. P. S., Baan J., Vis M. M., Tijssen J. G. P., Piek J. J., De Winter R. J., Two-year follow-up of the genous endothelial progenitor cell capturing stent versus the taxus libert stent in patients with de Novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheterization and Cardiovascular Interventions 2011 78 2 189 195 2-s2.0-79960702948 10.1002/ccd.23143
18. Sedaghat A., Sinning J. M., Paul K., First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model. Clinical Research in Cardiology 2013 102 6 413 425
19. Al-Azemi T. F., Bisht K. S., Novel functional polycarbonate by lipase-catalyzed ring-opening polymerization of 5-methyl-5-benzyloxycarbonyl-l, 3-dioxan-2-one. Macromolecules 1999 32 20 6536 6540 2-s2.0-0032595940
20. Juliane E., Stefanie K., Gergely J., Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovascular Research 2003 58 478 486
21. Meng S., Liu Z., Shen L., Guo Z., Chou L. L., Zhong W., Du Q., Ge J., The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009 30 12 2276 2283 2-s2.0-60549115600 10.1016/j.biomaterials.2008.12.075
22. Thorin E., Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. Journal of Cardiovascular Pharmacology 2001 38 1 90 98 2-s2.0-0034946831 10.1097/00005344-200107000-00010 (Pubitemid 32634993)
23. Kim J. W., Seo H. S., Park J. H., Na J. O., Choi C. U., Lim H. E., Kim E. J., Rha S.-W., Park C. G., Oh D. J., A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus versus a sirolimus-eluting stent. Differential recovery of coronary endothelial dysfunction. Journal of the American College of Cardiology 2009 53 18 1653 1659 2-s2.0-65249101325 10.1016/j.jacc.2009.01.051
24. den Dekker W. K., Houtgraaf J. H., Onuma Y., Benit E., de Winter R. J., Wijns W., Grisold M., Verheye S., Silber S., Teiger E., Rowland S. M., Ligtenberg E., Hill J., Wiemer M., den Heijer P., Rensing B. J., Channon K. M., Serruys P. W. J. C., Duckers H. J., Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (GenousStent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 2011 219 1 245 252 2-s2.0-80054968919 10.1016/j.atherosclerosis.2011.06.032